199 related articles for article (PubMed ID: 19922547)
1. Hypermethylation and transcriptional downregulation of the TIMP3 gene is associated with allelic loss on 22q12.3 and malignancy in meningiomas.
Barski D; Wolter M; Reifenberger G; Riemenschneider MJ
Brain Pathol; 2010 May; 20(3):623-31. PubMed ID: 19922547
[TBL] [Abstract][Full Text] [Related]
2. Molecular biological determinations of meningioma progression and recurrence.
Linsler S; Kraemer D; Driess C; Oertel J; Kammers K; Rahnenführer J; Ketter R; Urbschat S
PLoS One; 2014; 9(4):e94987. PubMed ID: 24722350
[TBL] [Abstract][Full Text] [Related]
3. Loss of heterozygosity analysis of benign, atypical, and anaplastic meningiomas.
Lee JY; Finkelstein S; Hamilton RL; Rekha R; King JT; Omalu B
Neurosurgery; 2004 Nov; 55(5):1163-73. PubMed ID: 15509323
[TBL] [Abstract][Full Text] [Related]
4. Genetic and epigenetic alteration of the NF2 gene in sporadic meningiomas.
Lomas J; Bello MJ; Arjona D; Alonso ME; Martinez-Glez V; Lopez-Marin I; Amiñoso C; de Campos JM; Isla A; Vaquero J; Rey JA
Genes Chromosomes Cancer; 2005 Mar; 42(3):314-9. PubMed ID: 15609345
[TBL] [Abstract][Full Text] [Related]
5. Aberrant DNA methylation of alternative promoter of DLC1 isoform 1 in meningiomas.
Bujko M; Kober P; Rusetska N; Wakuła M; Goryca K; Grecka E; Matyja E; Neska J; Mandat T; Bonicki W; Siedlecki JA
J Neurooncol; 2016 Dec; 130(3):473-484. PubMed ID: 27614886
[TBL] [Abstract][Full Text] [Related]
6. Malignant transformation-related genes in meningiomas: allelic loss on 1p36 and methylation status of p73 and RASSF1A.
Nakane Y; Natsume A; Wakabayashi T; Oi S; Ito M; Inao S; Saito K; Yoshida J
J Neurosurg; 2007 Aug; 107(2):398-404. PubMed ID: 17695396
[TBL] [Abstract][Full Text] [Related]
7. Analysis of the role of hMLH1 hypermethylation and microsatellite instability in meningioma progression.
Chen MN; Wang P; Zhang J; Zhou BY; Mao Q; Liu YH
Genet Mol Res; 2012 Nov; 11(4):3933-41. PubMed ID: 22930430
[TBL] [Abstract][Full Text] [Related]
8. NF2 gene mutations and allelic status of 1p, 14q and 22q in sporadic meningiomas.
Leone PE; Bello MJ; de Campos JM; Vaquero J; Sarasa JL; Pestaña A; Rey JA
Oncogene; 1999 Apr; 18(13):2231-9. PubMed ID: 10327069
[TBL] [Abstract][Full Text] [Related]
9. Allelic loss on chromosomes 1p32, 9p21, 13q14, 16q22, 17p, and 22q12 in meningiomas associated with meningioangiomatosis and pure meningioangiomatosis.
Kim NR; Cho SJ; Suh YL
J Neurooncol; 2009 Sep; 94(3):425-30. PubMed ID: 19347254
[TBL] [Abstract][Full Text] [Related]
10. Alterations of the tumor suppressor genes CDKN2A (p16(INK4a)), p14(ARF), CDKN2B (p15(INK4b)), and CDKN2C (p18(INK4c)) in atypical and anaplastic meningiomas.
Boström J; Meyer-Puttlitz B; Wolter M; Blaschke B; Weber RG; Lichter P; Ichimura K; Collins VP; Reifenberger G
Am J Pathol; 2001 Aug; 159(2):661-9. PubMed ID: 11485924
[TBL] [Abstract][Full Text] [Related]
11. Integrative genomic analysis identifies NDRG2 as a candidate tumor suppressor gene frequently inactivated in clinically aggressive meningioma.
Lusis EA; Watson MA; Chicoine MR; Lyman M; Roerig P; Reifenberger G; Gutmann DH; Perry A
Cancer Res; 2005 Aug; 65(16):7121-6. PubMed ID: 16103061
[TBL] [Abstract][Full Text] [Related]
12. Molecular genetics of meningiomas.
Ragel BT; Jensen RL
Neurosurg Focus; 2005 Nov; 19(5):E9. PubMed ID: 16398473
[TBL] [Abstract][Full Text] [Related]
13. [Aberrant methylation of NF2, TIMP-3 and THBS1 genes and their diagnostic values in meningiomas].
Gong J; Zhu SG; Wu CY; Li XG; Liu YG; Ren XH; Zhang Y
Zhonghua Yi Xue Za Zhi; 2012 Nov; 92(41):2889-92. PubMed ID: 23328233
[TBL] [Abstract][Full Text] [Related]
14. Genetic and epigenetic alterations in meningiomas.
Galani V; Lampri E; Varouktsi A; Alexiou G; Mitselou A; Kyritsis AP
Clin Neurol Neurosurg; 2017 Jul; 158():119-125. PubMed ID: 28527972
[TBL] [Abstract][Full Text] [Related]
15. DNA microarray analysis identifies CKS2 and LEPR as potential markers of meningioma recurrence.
Menghi F; Orzan FN; Eoli M; Farinotti M; Maderna E; Pisati F; Bianchessi D; Valletta L; Lodrini S; Galli G; Anghileri E; Pellegatta S; Pollo B; Finocchiaro G
Oncologist; 2011; 16(10):1440-50. PubMed ID: 21948653
[TBL] [Abstract][Full Text] [Related]
16. Altered expression of beta-catenin/E-cadherin in meningiomas.
Brunner EC; Romeike BF; Jung M; Comtesse N; Meese E
Histopathology; 2006 Aug; 49(2):178-87. PubMed ID: 16879395
[TBL] [Abstract][Full Text] [Related]
17. Allelic losses in neurofibromatosis 2-associated meningiomas.
Lamszus K; Vahldiek F; Mautner VF; Schichor C; Tonn J; Stavrou D; Fillbrandt R; Westphal M; Kluwe L
J Neuropathol Exp Neurol; 2000 Jun; 59(6):504-12. PubMed ID: 10850863
[TBL] [Abstract][Full Text] [Related]
18. Allelic losses at 1p, 9q, 10q, 14q, and 22q in the progression of aggressive meningiomas and undifferentiated meningeal sarcomas.
Lamszus K; Kluwe L; Matschke J; Meissner H; Laas R; Westphal M
Cancer Genet Cytogenet; 1999 Apr; 110(2):103-10. PubMed ID: 10214357
[TBL] [Abstract][Full Text] [Related]
19. The molecular genetics and tumor pathogenesis of meningiomas and the future directions of meningioma treatments.
Choy W; Kim W; Nagasawa D; Stramotas S; Yew A; Gopen Q; Parsa AT; Yang I
Neurosurg Focus; 2011 May; 30(5):E6. PubMed ID: 21529177
[TBL] [Abstract][Full Text] [Related]
20. Aberrant CpG island hypermethylation profile is associated with atypical and anaplastic meningiomas.
Liu Y; Pang JC; Dong S; Mao B; Poon WS; Ng HK
Hum Pathol; 2005 Apr; 36(4):416-25. PubMed ID: 15892004
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
